 | • レポートコード：GIR-105X01056 • 出版社/出版日：GlobalInfoResearch / 2021年5月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、抗CD20モノクローナル抗体のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。抗CD20モノクローナル抗体の種類別市場規模（第1世代抗CD20モノクローナル抗体、第2世代抗CD20モノクローナル抗体、第3世代抗CD20モノクローナル抗体）、用途別市場規模（腫瘍、神経、免疫）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・抗CD20モノクローナル抗体の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Genmab、Amgen、Celltrion、Roche、Novartis AG、Pfizer、Biogen、Genentech、Immunomedics、Spectrum Pharmaceuticals、Bio-Rad Laboratories、LFB Biotechnologie ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：第1世代抗CD20モノクローナル抗体、第2世代抗CD20モノクローナル抗体、第3世代抗CD20モノクローナル抗体 ・用途別分析2016年-2026年：腫瘍、神経、免疫 ・抗CD20モノクローナル抗体の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・抗CD20モノクローナル抗体のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・抗CD20モノクローナル抗体のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・抗CD20モノクローナル抗体の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・抗CD20モノクローナル抗体の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Anti-CD20 Monoclonal Antibodies market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Anti-CD20 Monoclonal Antibodies size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Anti-CD20 Monoclonal Antibodies market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Anti-CD20 Monoclonal Antibodies market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
First Generation Anti-CD20 Monoclonal Antibody
Second Generation Anti-CD20 Monoclonal Antibody
Third Generation Anti-CD20 Monoclonal Antibody
Market segment by Application can be divided into
Oncology
Neurology
Immunology
The key market players for global Anti-CD20 Monoclonal Antibodies market are listed below:
Genmab
Amgen
Celltrion
Roche
Novartis AG
Pfizer
Biogen
Genentech
Immunomedics
Spectrum Pharmaceuticals
Bio-Rad Laboratories
LFB Biotechnologie
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Anti-CD20 Monoclonal Antibodies Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Anti-CD20 Monoclonal Antibodies Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 First Generation Anti-CD20 Monoclonal Antibody
1.2.3 Second Generation Anti-CD20 Monoclonal Antibody
1.2.4 Third Generation Anti-CD20 Monoclonal Antibody
1.3 Market Analysis by Application
1.3.1 Overview: Global Anti-CD20 Monoclonal Antibodies Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Oncology
1.3.3 Neurology
1.3.4 Immunology
1.4 Global Anti-CD20 Monoclonal Antibodies Market Size & Forecast
1.4.1 Global Anti-CD20 Monoclonal Antibodies Sales in Value (2016-2026))
1.4.2 Global Anti-CD20 Monoclonal Antibodies Sales in Volume (2016-2026)
1.4.3 Global Anti-CD20 Monoclonal Antibodies Price by Type (2016-2026) & (USD/KG)
1.5 Global Anti-CD20 Monoclonal Antibodies Production Capacity Analysis
1.5.1 Global Anti-CD20 Monoclonal Antibodies Total Production Capacity (2016-2026)
1.5.2 Global Anti-CD20 Monoclonal Antibodies Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Anti-CD20 Monoclonal Antibodies Market Drivers
1.6.2 Anti-CD20 Monoclonal Antibodies Market Restraints
1.6.3 Anti-CD20 Monoclonal Antibodies Trends Analysis
2 Manufacturers Profiles
2.1 Genmab
2.1.1 Genmab Details
2.1.2 Genmab Major Business
2.1.3 Genmab Anti-CD20 Monoclonal Antibodies Product and Services
2.1.4 Genmab Anti-CD20 Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Amgen
2.2.1 Amgen Details
2.2.2 Amgen Major Business
2.2.3 Amgen Anti-CD20 Monoclonal Antibodies Product and Services
2.2.4 Amgen Anti-CD20 Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Celltrion
2.3.1 Celltrion Details
2.3.2 Celltrion Major Business
2.3.3 Celltrion Anti-CD20 Monoclonal Antibodies Product and Services
2.3.4 Celltrion Anti-CD20 Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Roche
2.4.1 Roche Details
2.4.2 Roche Major Business
2.4.3 Roche Anti-CD20 Monoclonal Antibodies Product and Services
2.4.4 Roche Anti-CD20 Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Novartis AG
2.5.1 Novartis AG Details
2.5.2 Novartis AG Major Business
2.5.3 Novartis AG Anti-CD20 Monoclonal Antibodies Product and Services
2.5.4 Novartis AG Anti-CD20 Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Pfizer
2.6.1 Pfizer Details
2.6.2 Pfizer Major Business
2.6.3 Pfizer Anti-CD20 Monoclonal Antibodies Product and Services
2.6.4 Pfizer Anti-CD20 Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Biogen
2.7.1 Biogen Details
2.7.2 Biogen Major Business
2.7.3 Biogen Anti-CD20 Monoclonal Antibodies Product and Services
2.7.4 Biogen Anti-CD20 Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Genentech
2.8.1 Genentech Details
2.8.2 Genentech Major Business
2.8.3 Genentech Anti-CD20 Monoclonal Antibodies Product and Services
2.8.4 Genentech Anti-CD20 Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Immunomedics
2.9.1 Immunomedics Details
2.9.2 Immunomedics Major Business
2.9.3 Immunomedics Anti-CD20 Monoclonal Antibodies Product and Services
2.9.4 Immunomedics Anti-CD20 Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Spectrum Pharmaceuticals
2.10.1 Spectrum Pharmaceuticals Details
2.10.2 Spectrum Pharmaceuticals Major Business
2.10.3 Spectrum Pharmaceuticals Anti-CD20 Monoclonal Antibodies Product and Services
2.10.4 Spectrum Pharmaceuticals Anti-CD20 Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 Bio-Rad Laboratories
2.11.1 Bio-Rad Laboratories Details
2.11.2 Bio-Rad Laboratories Major Business
2.11.3 Bio-Rad Laboratories Anti-CD20 Monoclonal Antibodies Product and Services
2.11.4 Bio-Rad Laboratories Anti-CD20 Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.12 LFB Biotechnologie
2.12.1 LFB Biotechnologie Details
2.12.2 LFB Biotechnologie Major Business
2.12.3 LFB Biotechnologie Anti-CD20 Monoclonal Antibodies Product and Services
2.12.4 LFB Biotechnologie Anti-CD20 Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Anti-CD20 Monoclonal Antibodies Sales by Manufacturer
3.1 Global Anti-CD20 Monoclonal Antibodies Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Anti-CD20 Monoclonal Antibodies Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Anti-CD20 Monoclonal Antibodies
3.4 Market Concentration Rate
3.4.1 Top 3 Anti-CD20 Monoclonal Antibodies Manufacturer Market Share
3.4.2 Top 6 Anti-CD20 Monoclonal Antibodies Manufacturer Market Share
3.5 Global Anti-CD20 Monoclonal Antibodies Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Anti-CD20 Monoclonal Antibodies Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Anti-CD20 Monoclonal Antibodies Market Size by Region
4.1.1 Global Anti-CD20 Monoclonal Antibodies Sales in Volume by Region (2016-2026)
4.1.2 Global Anti-CD20 Monoclonal Antibodies Revenue by Region (2016-2026)
4.2 North America Anti-CD20 Monoclonal Antibodies Revenue (2016-2026)
4.3 Europe Anti-CD20 Monoclonal Antibodies Revenue (2016-2026)
4.4 Asia-Pacific Anti-CD20 Monoclonal Antibodies Revenue (2016-2026)
4.5 South America Anti-CD20 Monoclonal Antibodies Revenue (2016-2026)
4.6 Middle East and Africa Anti-CD20 Monoclonal Antibodies Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Anti-CD20 Monoclonal Antibodies Sales in Volume by Type (2016-2026)
5.2 Global Anti-CD20 Monoclonal Antibodies Revenue by Type (2016-2026)
5.3 Global Anti-CD20 Monoclonal Antibodies Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Anti-CD20 Monoclonal Antibodies Sales in Volume by Application (2016-2026)
6.2 Global Anti-CD20 Monoclonal Antibodies Revenue by Application (2016-2026)
6.3 Global Anti-CD20 Monoclonal Antibodies Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Anti-CD20 Monoclonal Antibodies Sales by Type (2016-2026)
7.2 North America Anti-CD20 Monoclonal Antibodies Sales by Application (2016-2026)
7.3 North America Anti-CD20 Monoclonal Antibodies Market Size by Country
7.3.1 North America Anti-CD20 Monoclonal Antibodies Sales in Volume by Country (2016-2026)
7.3.2 North America Anti-CD20 Monoclonal Antibodies Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Anti-CD20 Monoclonal Antibodies Sales by Type (2016-2026)
8.2 Europe Anti-CD20 Monoclonal Antibodies Sales by Application (2016-2026)
8.3 Europe Anti-CD20 Monoclonal Antibodies Market Size by Country
8.3.1 Europe Anti-CD20 Monoclonal Antibodies Sales in Volume by Country (2016-2026)
8.3.2 Europe Anti-CD20 Monoclonal Antibodies Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Anti-CD20 Monoclonal Antibodies Sales by Type (2016-2026)
9.2 Asia-Pacific Anti-CD20 Monoclonal Antibodies Sales by Application (2016-2026)
9.3 Asia-Pacific Anti-CD20 Monoclonal Antibodies Market Size by Region
9.3.1 Asia-Pacific Anti-CD20 Monoclonal Antibodies Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Anti-CD20 Monoclonal Antibodies Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Anti-CD20 Monoclonal Antibodies Sales by Type (2016-2026)
10.2 South America Anti-CD20 Monoclonal Antibodies Sales by Application (2016-2026)
10.3 South America Anti-CD20 Monoclonal Antibodies Market Size by Country
10.3.1 South America Anti-CD20 Monoclonal Antibodies Sales in Volume by Country (2016-2026)
10.3.2 South America Anti-CD20 Monoclonal Antibodies Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Anti-CD20 Monoclonal Antibodies Sales by Type (2016-2026)
11.2 Middle East & Africa Anti-CD20 Monoclonal Antibodies Sales by Application (2016-2026)
11.3 Middle East & Africa Anti-CD20 Monoclonal Antibodies Market Size by Country
11.3.1 Middle East & Africa Anti-CD20 Monoclonal Antibodies Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Anti-CD20 Monoclonal Antibodies Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Anti-CD20 Monoclonal Antibodies Typical Distributors
12.3 Anti-CD20 Monoclonal Antibodies Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Anti-CD20 Monoclonal Antibodies Revenue by Type, (USD Million), 2021-2026
Table 2. Global Anti-CD20 Monoclonal Antibodies Revenue by Application, (USD Million), 2021-2026
Table 3. Genmab Basic Information, Manufacturing Base and Competitors
Table 4. Genmab Major Business
Table 5. Genmab Anti-CD20 Monoclonal Antibodies Product and Services
Table 6. Genmab Anti-CD20 Monoclonal Antibodies Sales (KG), Price (USD/KG), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Amgen Basic Information, Manufacturing Base and Competitors
Table 8. Amgen Major Business
Table 9. Amgen Anti-CD20 Monoclonal Antibodies Product and Services
Table 10. Amgen Anti-CD20 Monoclonal Antibodies Sales (KG), Price (USD/KG), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Celltrion Basic Information, Manufacturing Base and Competitors
Table 12. Celltrion Major Business
Table 13. Celltrion Anti-CD20 Monoclonal Antibodies Product and Services
Table 14. Celltrion Anti-CD20 Monoclonal Antibodies Sales (KG), Price (USD/KG), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Roche Basic Information, Manufacturing Base and Competitors
Table 16. Roche Major Business
Table 17. Roche Anti-CD20 Monoclonal Antibodies Product and Services
Table 18. Roche Anti-CD20 Monoclonal Antibodies Sales (KG), Price (USD/KG), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 20. Novartis AG Major Business
Table 21. Novartis AG Anti-CD20 Monoclonal Antibodies Product and Services
Table 22. Novartis AG Anti-CD20 Monoclonal Antibodies Sales (KG), Price (USD/KG), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Pfizer Basic Information, Manufacturing Base and Competitors
Table 24. Pfizer Major Business
Table 25. Pfizer Anti-CD20 Monoclonal Antibodies Product and Services
Table 26. Pfizer Anti-CD20 Monoclonal Antibodies Sales (KG), Price (USD/KG), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Biogen Basic Information, Manufacturing Base and Competitors
Table 28. Biogen Major Business
Table 29. Biogen Anti-CD20 Monoclonal Antibodies Product and Services
Table 30. Biogen Anti-CD20 Monoclonal Antibodies Sales (KG), Price (USD/KG), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Genentech Basic Information, Manufacturing Base and Competitors
Table 32. Genentech Major Business
Table 33. Genentech Anti-CD20 Monoclonal Antibodies Product and Services
Table 34. Genentech Anti-CD20 Monoclonal Antibodies Sales (KG), Price (USD/KG), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Immunomedics Basic Information, Manufacturing Base and Competitors
Table 36. Immunomedics Major Business
Table 37. Immunomedics Anti-CD20 Monoclonal Antibodies Product and Services
Table 38. Immunomedics Anti-CD20 Monoclonal Antibodies Sales (KG), Price (USD/KG), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Spectrum Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 40. Spectrum Pharmaceuticals Major Business
Table 41. Spectrum Pharmaceuticals Anti-CD20 Monoclonal Antibodies Product and Services
Table 42. Spectrum Pharmaceuticals Anti-CD20 Monoclonal Antibodies Sales (KG), Price (USD/KG), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Bio-Rad Laboratories Basic Information, Manufacturing Base and Competitors
Table 44. Bio-Rad Laboratories Major Business
Table 45. Bio-Rad Laboratories Anti-CD20 Monoclonal Antibodies Product and Services
Table 46. Bio-Rad Laboratories Anti-CD20 Monoclonal Antibodies Sales (KG), Price (USD/KG), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. LFB Biotechnologie Basic Information, Manufacturing Base and Competitors
Table 48. LFB Biotechnologie Major Business
Table 49. LFB Biotechnologie Anti-CD20 Monoclonal Antibodies Product and Services
Table 50. LFB Biotechnologie Anti-CD20 Monoclonal Antibodies Sales (KG), Price (USD/KG), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Global Anti-CD20 Monoclonal Antibodies Sales by Manufacturer (2019-2021e) & (KG)
Table 52. Global Anti-CD20 Monoclonal Antibodies Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 53. Market Position of Manufacturers in Anti-CD20 Monoclonal Antibodies, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 54. Global Anti-CD20 Monoclonal Antibodies Production Capacity by Company, (KG): 2020 VS 2021
Table 55. Head Office and Anti-CD20 Monoclonal Antibodies Production Site of Key Manufacturer
Table 56. Global Anti-CD20 Monoclonal Antibodies Sales by Region (2016-2021e) & (KG)
Table 57. Global Anti-CD20 Monoclonal Antibodies Sales by Region (2021-2026) & (KG)
Table 58. Global Anti-CD20 Monoclonal Antibodies Revenue by Region (2016-2021e) & (USD Million)
Table 59. Global Anti-CD20 Monoclonal Antibodies Revenue by Region (2021-2026) & (USD Million)
Table 60. Global Anti-CD20 Monoclonal Antibodies Sales by Type (2016-2021e) & (KG)
Table 61. Global Anti-CD20 Monoclonal Antibodies Sales by Type (2021-2026) & (KG)
Table 62. Global Anti-CD20 Monoclonal Antibodies Revenue by Type (2016-2021e) & (USD Million)
Table 63. Global Anti-CD20 Monoclonal Antibodies Revenue by Type (2021-2026) & (USD Million)
Table 64. Global Anti-CD20 Monoclonal Antibodies Price by Type (2016-2021e) & (USD/KG)
Table 65. Global Anti-CD20 Monoclonal Antibodies Price by Type (2021-2026) & (USD/KG)
Table 66. Global Anti-CD20 Monoclonal Antibodies Sales by Application (2016-2021e) & (KG)
Table 67. Global Anti-CD20 Monoclonal Antibodies Sales by Application (2021-2026) & (KG)
Table 68. Global Anti-CD20 Monoclonal Antibodies Revenue by Application (2016-2021e) & (USD Million)
Table 69. Global Anti-CD20 Monoclonal Antibodies Revenue by Application (2021-2026) & (USD Million)
Table 70. Global Anti-CD20 Monoclonal Antibodies Price by Application (2016-2021e) & (USD/KG)
Table 71. Global Anti-CD20 Monoclonal Antibodies Price by Application (2021-2026) & (USD/KG)
Table 72. North America Anti-CD20 Monoclonal Antibodies Sales by Country (2016-2021e) & (KG)
Table 73. North America Anti-CD20 Monoclonal Antibodies Sales by Country (2021-2026) & (KG)
Table 74. North America Anti-CD20 Monoclonal Antibodies Revenue by Country (2016-2021e) & (USD Million)
Table 75. North America Anti-CD20 Monoclonal Antibodies Revenue by Country (2021-2026) & (USD Million)
Table 76. North America Anti-CD20 Monoclonal Antibodies Sales by Type (2016-2021e) & (KG)
Table 77. North America Anti-CD20 Monoclonal Antibodies Sales by Type (2021-2026) & (KG)
Table 78. North America Anti-CD20 Monoclonal Antibodies Sales by Application (2016-2021e) & (KG)
Table 79. North America Anti-CD20 Monoclonal Antibodies Sales by Application (2021-2026) & (KG)
Table 80. Europe Anti-CD20 Monoclonal Antibodies Sales by Country (2016-2021e) & (KG)
Table 81. Europe Anti-CD20 Monoclonal Antibodies Sales by Country (2021-2026) & (KG)
Table 82. Europe Anti-CD20 Monoclonal Antibodies Revenue by Country (2016-2021e) & (USD Million)
Table 83. Europe Anti-CD20 Monoclonal Antibodies Revenue by Country (2021-2026) & (USD Million)
Table 84. Europe Anti-CD20 Monoclonal Antibodies Sales by Type (2016-2021e) & (KG)
Table 85. Europe Anti-CD20 Monoclonal Antibodies Sales by Type (2021-2026) & (KG)
Table 86. Europe Anti-CD20 Monoclonal Antibodies Sales by Application (2016-2021e) & (KG)
Table 87. Europe Anti-CD20 Monoclonal Antibodies Sales by Application (2021-2026) & (KG)
Table 88. Asia-Pacific Anti-CD20 Monoclonal Antibodies Sales by Region (2016-2021e) & (KG)
Table 89. Asia-Pacific Anti-CD20 Monoclonal Antibodies Sales by Region (2021-2026) & (KG)
Table 90. Asia-Pacific Anti-CD20 Monoclonal Antibodies Revenue by Region (2016-2021e) & (USD Million)
Table 91. Asia-Pacific Anti-CD20 Monoclonal Antibodies Revenue by Region (2021-2026) & (USD Million)
Table 92. Asia-Pacific Anti-CD20 Monoclonal Antibodies Sales by Type (2016-2021e) & (KG)
Table 93. Asia-Pacific Anti-CD20 Monoclonal Antibodies Sales by Type (2021-2026) & (KG)
Table 94. Asia-Pacific Anti-CD20 Monoclonal Antibodies Sales by Application (2016-2021e) & (KG)
Table 95. Asia-Pacific Anti-CD20 Monoclonal Antibodies Sales by Application (2021-2026) & (KG)
Table 96. South America Anti-CD20 Monoclonal Antibodies Sales by Country (2016-2021e) & (KG)
Table 97. South America Anti-CD20 Monoclonal Antibodies Sales by Country (2021-2026) & (KG)
Table 98. South America Anti-CD20 Monoclonal Antibodies Revenue by Country (2016-2021e) & (USD Million)
Table 99. South America Anti-CD20 Monoclonal Antibodies Revenue by Country (2021-2026) & (USD Million)
Table 100. South America Anti-CD20 Monoclonal Antibodies Sales by Type (2016-2021e) & (KG)
Table 101. South America Anti-CD20 Monoclonal Antibodies Sales by Type (2021-2026) & (KG)
Table 102. South America Anti-CD20 Monoclonal Antibodies Sales by Application (2016-2021e) & (KG)
Table 103. South America Anti-CD20 Monoclonal Antibodies Sales by Application (2021-2026) & (KG)
Table 104. Middle East & Africa Anti-CD20 Monoclonal Antibodies Sales by Country (2016-2021e) & (KG)
Table 105. Middle East & Africa Anti-CD20 Monoclonal Antibodies Sales by Country (2021-2026) & (KG)
Table 106. Middle East & Africa Anti-CD20 Monoclonal Antibodies Revenue by Country (2016-2021e) & (USD Million)
Table 107. Middle East & Africa Anti-CD20 Monoclonal Antibodies Revenue by Country (2021-2026) & (USD Million)
Table 108. Middle East & Africa Anti-CD20 Monoclonal Antibodies Sales by Type (2016-2021e) & (KG)
Table 109. Middle East & Africa Anti-CD20 Monoclonal Antibodies Sales by Type (2021-2026) & (KG)
Table 110. Middle East & Africa Anti-CD20 Monoclonal Antibodies Sales by Application (2016-2021e) & (KG)
Table 111. Middle East & Africa Anti-CD20 Monoclonal Antibodies Sales by Application (2021-2026) & (KG)
Table 112. Direct Channel Pros & Cons
Table 113. Indirect Channel Pros & Cons
Table 114. Anti-CD20 Monoclonal Antibodies Typical Distributors
Table 115. Anti-CD20 Monoclonal Antibodies Typical Customers
List of Figures
Figure 1. Anti-CD20 Monoclonal Antibodies Picture
Figure 2. Global Anti-CD20 Monoclonal Antibodies Sales Market Share by Type in 2020
Figure 3. First Generation Anti-CD20 Monoclonal Antibody
Figure 4. Second Generation Anti-CD20 Monoclonal Antibody
Figure 5. Third Generation Anti-CD20 Monoclonal Antibody
Figure 6. Global Anti-CD20 Monoclonal Antibodies Sales Market Share by Application in 2020
Figure 7. Oncology
Figure 8. Neurology
Figure 9. Immunology
Figure 10. Global Anti-CD20 Monoclonal Antibodies Market Size, (USD Million) & (KG): 2020 VS 2021 VS 2026
Figure 11. Global Anti-CD20 Monoclonal Antibodies Market Size and Forecast (2016-2026) & (USD Million)
Figure 12. United States Anti-CD20 Monoclonal Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Canada Anti-CD20 Monoclonal Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Mexico Anti-CD20 Monoclonal Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Germany Anti-CD20 Monoclonal Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. France Anti-CD20 Monoclonal Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. United Kingdom Anti-CD20 Monoclonal Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Russia Anti-CD20 Monoclonal Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Italy Anti-CD20 Monoclonal Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. China Anti-CD20 Monoclonal Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Japan Anti-CD20 Monoclonal Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Korea Anti-CD20 Monoclonal Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. India Anti-CD20 Monoclonal Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Southeast Asia Anti-CD20 Monoclonal Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Australia Anti-CD20 Monoclonal Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Brazil Anti-CD20 Monoclonal Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Egypt Anti-CD20 Monoclonal Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Saudi Arabia Anti-CD20 Monoclonal Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. South Africa Anti-CD20 Monoclonal Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Turkey Anti-CD20 Monoclonal Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Global Anti-CD20 Monoclonal Antibodies Sales (2016-2026) & (KG)
Figure 32. Global Anti-CD20 Monoclonal Antibodies Production Capacity (2016-2026) & (KG)
Figure 33. Global Anti-CD20 Monoclonal Antibodies Production Capacity by Geographic Region: 2020 VS 2021
Figure 34. Anti-CD20 Monoclonal Antibodies Market Drivers
Figure 35. Anti-CD20 Monoclonal Antibodies Market Restraints
Figure 36. Anti-CD20 Monoclonal Antibodies Market Trends
Figure 37. Global Anti-CD20 Monoclonal Antibodies Sales Market Share by Manufacturer in 2020
Figure 38. Global Anti-CD20 Monoclonal Antibodies Revenue Market Share by Manufacturer in 2020
Figure 39. Anti-CD20 Monoclonal Antibodies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 40. Top 3 Anti-CD20 Monoclonal Antibodies Manufacturer (Revenue) Market Share in 2020
Figure 41. Top 6 Anti-CD20 Monoclonal Antibodies Manufacturer (Revenue) Market Share in 2020
Figure 42. Global Anti-CD20 Monoclonal Antibodies Sales Market Share by Region (2016-2026)
Figure 43. Global Anti-CD20 Monoclonal Antibodies Revenue Market Share by Region (2016-2026)
Figure 44. North America Anti-CD20 Monoclonal Antibodies Revenue (2016-2026) & (USD Million)
Figure 45. Europe Anti-CD20 Monoclonal Antibodies Revenue (2016-2026) & (USD Million)
Figure 46. Asia-Pacific Anti-CD20 Monoclonal Antibodies Revenue (2016-2026) & (USD Million)
Figure 47. South America Anti-CD20 Monoclonal Antibodies Revenue (2016-2026) & (USD Million)
Figure 48. Middle East & Africa Anti-CD20 Monoclonal Antibodies Revenue (2016-2026) & (USD Million)
Figure 49. Global Anti-CD20 Monoclonal Antibodies Sales Market Share by Type (2016-2026)
Figure 50. Global Anti-CD20 Monoclonal Antibodies Revenue Market Share by Type (2016-2026)
Figure 51. Global Anti-CD20 Monoclonal Antibodies Price by Type (2016-2026) & (USD/KG)
Figure 52. Global Anti-CD20 Monoclonal Antibodies Sales Market Share by Application (2016-2026)
Figure 53. Global Anti-CD20 Monoclonal Antibodies Revenue Market Share by Application (2016-2026)
Figure 54. Global Anti-CD20 Monoclonal Antibodies Price by Application (2016-2026) & (USD/KG)
Figure 55. North America Anti-CD20 Monoclonal Antibodies Sales Market Share by Country (2016-2026)
Figure 56. North America Anti-CD20 Monoclonal Antibodies Revenue Market Share by Country (2016-2026)
Figure 57. North America Anti-CD20 Monoclonal Antibodies Sales Market Share by Type (2016-2026)
Figure 58. North America Anti-CD20 Monoclonal Antibodies Sales Market Share by Application (2016-2026)
Figure 59. Europe Anti-CD20 Monoclonal Antibodies Sales Market Share by Country (2016-2026)
Figure 60. Europe Anti-CD20 Monoclonal Antibodies Revenue Market Share by Country (2016-2026)
Figure 61. Europe Anti-CD20 Monoclonal Antibodies Sales Market Share by Type (2016-2026)
Figure 62. Europe Anti-CD20 Monoclonal Antibodies Sales Market Share by Application (2016-2026)
Figure 63. Asia-Pacific Anti-CD20 Monoclonal Antibodies Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Anti-CD20 Monoclonal Antibodies Revenue Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Anti-CD20 Monoclonal Antibodies Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Anti-CD20 Monoclonal Antibodies Sales Market Share by Application (2016-2026)
Figure 67. South America Anti-CD20 Monoclonal Antibodies Sales Market Share by Country (2016-2026)
Figure 68. South America Anti-CD20 Monoclonal Antibodies Revenue Market Share by Country (2016-2026)
Figure 69. South America Anti-CD20 Monoclonal Antibodies Sales Market Share by Type (2016-2026)
Figure 70. South America Anti-CD20 Monoclonal Antibodies Sales Market Share by Application (2016-2026)
Figure 71. Middle East & Africa Anti-CD20 Monoclonal Antibodies Sales Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Anti-CD20 Monoclonal Antibodies Revenue Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Anti-CD20 Monoclonal Antibodies Sales Market Share by Type (2016-2026)
Figure 74. Middle East & Africa Anti-CD20 Monoclonal Antibodies Sales Market Share by Application (2016-2026)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source
モノクローナル抗体（mAb）バイオシミラーの世界市場予測 2023年：メーカー別、地域別、種類・用途別 A biosimilar medicine is a medicinal product of biological origin that is produced in a living organism following a procedure equivalent to a biological drug and adhering to the same quality criteria, hence the name biosimilars. In short, they are biological drugs that are “equivalent” in terms of q…- 世界のモノクローナル抗体滅菌注射薬市場 2021：企業別、地域別、種類・用途別 The Monoclonal Antibodies Sterile Injectable Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain opti…
- 全身性エリテマトーデス（SLE）薬の世界市場予測 2023年：メーカー別、地域別、種類・用途別 SLE is the most common form of lupus and is also called lupus. It is a chronic, autoimmune disease with signs and symptoms that can last for six months or for many years. It can affect any part of the body, such as the skin, joints, and organs (LFA, 2012). SLE occurs when the immune system produces …
- B3GALNT2/B3GL2抗体の世界市場2018-2025 In 2018, the global B3GALNT2/B3GL2 Antibody market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for B3GALNT2/B3GL2 Antibody. Thi…
- 組み換え治療用抗体とタンパク質の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Therapeutic proteins are engineered in the laboratory for pharmaceutical use, including non-covalent binders. These proteins are highly effective and serve as modernized treatment for rare as well as chronic diseases. Protein therapeutics offer custom-made treatment approach by supporting a specific…